Cite Filings / IMVT / 0000000000-24-002245
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
UPLOAD

SEC-generated Letter

Immunovant, Inc. · Filed 2024-02-28 · Acc 0000000000-24-002245

Documents 1

  • UPLOAD SEC-generated Letter , filename1.pdf

Around this filing

  • 2024-02-28 UPLOAD SEC-generated Letter
  • 2024-02-23 4 Chief Financial Officer sold 2,930 shares at $36.15 ($105,920)
  • 2024-02-23 4 Chief Legal Officer sold 2,134 shares at $36.15 ($77,144)
  • 2024-02-23 4 Chief Medical Officer sold 2,221 shares at $36.15 ($80,289)
  • 2024-02-23 4 Chief Development Officer sold 2,146 shares at $36.15 ($77,578)
  • 2024-02-23 4 Chief Executive Officer sold 13,454 shares at $36.15 ($486,362)
  • 2024-01-17 UPLOAD SEC-generated Letter

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading filename1.pdf…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…